文献速递肺外科

临床IA3期非小细胞肺癌肺叶切除与亚肺叶切除的结局比较

Outcomes of Lobectomy vs Sublobar Resection for Clinical Stage IA3 Non-Small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2026-06-22

单中心回顾性研究纳入2015-2024年260例临床IA3期NSCLC切除患者,比较楔形切除、解剖性肺段切除与肺叶切除的结局。楔形切除者复发更多、无病生存更差;肺段切除与肺叶切除结局相当。

要点

  • 楔形切除后复发率27.5%,高于肺段切除16.4%和肺叶切除11.8%。
  • 3年无病生存:楔形切除76.8%,肺段切除82.7%,肺叶切除90.9%。
  • 肺段切除与肺叶切除在IA3期NSCLC中结局相当。

核心结论

  • 在临床IA3期NSCLC中,肺叶切除与肺段切除结局相当,而楔形切除与更高复发和更差无病生存相关。

研究设计与样本

  • 单中心回顾性研究,纳入2015-2024年临床IA3期NSCLC接受切除的患者260例。
  • 按楔形切除40例(15.4%)、解剖性肺段切除67例(25.8%)、肺叶切除153例(58.8%)分层。
  • 排除接受新辅助治疗者和神经内分泌肿瘤患者。
  • 采用Kaplan-Meier法和多变量Cox回归模型评估结局。

临床怎么用

  • 对于临床IA3期NSCLC,肺段切除可作为肺叶切除的替代选择,而楔形切除应谨慎使用。
  • 楔形切除与更高复发和更差无病生存相关,选择该术式需充分评估风险。

局限性

  • 单中心回顾性研究,样本量有限,可能存在选择偏倚。
  • 三组淋巴结清扫数目存在显著差异,可能影响分期和结局比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent trials demonstrate comparable outcomes between sublobar resection (SLR) and lobar resection (LR) for stage IA1-2 (≤2 cm) non-small cell lung cancer (NSCLC). Conversely, historical studies reported more recurrences with SLR than with LR for stage IA3 NSCLC (>2 cm, ≤3 cm), although these investigations predated diagnostic and therapeutic advancements. We aimed to compare SLR and LR outcomes in these patients in the contemporary era. METHODS: Patients assigned to clinical stage IA3 NSCLC undergoing resection at a single institution (2015-2024) were stratified by wedge resection, anatomic segmentectomy, or LR. Patients with neoadjuvant therapy receipt and neuroendocrine tumors were excluded. Outcomes were evaluated by Kaplan-Meier and multivariable Cox regression models. RESULTS: We identified 260 individuals: 40 (15.4%) underwent wedge resection, 67 (25.8%) segmentectomy, and 153 (58.8%) LR. Most patients were male (wedge, n = 14/40 [35.0%]; segmentectomy, n = 30/67 [45.0%]; LR, n = 65/153 [42.5%]; P = .59). Groups differed in median number of lymph nodes harvested (wedge, 6 [4-8]; segmentectomy, 11 [7-15]; LR, 14 [9.5-18.5]; P < .01). Recurrences were more frequent after wedge resection (wedge, n = 11/40 [27.5%]; segmentectomy, n = 11/67 [16.4%]; LR, n = 18/153 [11.8%]; P = .04). At median follow-up (42.8 months), 3-year disease-free survival for wedge resection patients was 76.8% (95% CI, 63.7-92.7) compared with 82.7% (95% CI, 73.4-93.1) for segmentectomy patients and 90.9% (95% CI, 85.8-96.2; P = .03) for LR patients. CONCLUSIONS: LR and segmentectomy achieved comparable outcomes in stage IA3 NSCLC, whereas wedge resection was associated with higher recurrence and inferior disease-free survival. These data contribute to discussions about the role of SLR in treating this subgroup of patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Hooda Z, Ries S, McCracken A, et al. Outcomes of Lobectomy vs Sublobar Resection for Clinical Stage IA3 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2026. PMID: 42331211. doi:10.1016/j.athoracsur.2026.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。